• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
98% Bifida Ferment Lysate
rhSOD (cosmetic grade)
Recombinant humanized collagen
Recombinant Humanized Small-molecule Collagen
Recombinant Humanized Small-molecule Collagen Solution
rhSOD

Japan’s cabinet approves plan for free COVID-19 vaccines

expresspharmaOctober 29, 2020

Tag: Japan , COVID-19 vaccine , coronavirus

Japan’s cabinet approved a plan on Tuesday to use public funds to provide novel coronavirus vaccines to the public for free.

The plan also calls for the government to bear the cost of any health damage caused by a vaccine, according to a document posted on the health ministry’s website.

Prime Minister Yoshihide Suga has pledged to provide enough vaccines for the coronavirus for the public by mid-2021.

Japan has struck deals for hundreds of millions of doses from companies including AstraZeneca and Pfizer.

Previous:Russia applies for WHO emergency use tag for its COVID-19 vaccine

Next:PMI announces Medicago to supply up to 76 mn doses of its plant-derived COVID-19 vaccine candidate

Related News

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PRNewswireDecember 19, 2024

A New Premium Supplements Brand, Launched Officially on November 18th on IM8health.com

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PRNewswireDecember 19, 2024

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

PRNewswireDecember 20, 2024

Japan’s cabinet approves plan for free COVID-19 vaccines | Pharmasources.com

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

PRNewswireDecember 21, 2024

Corvia Medical, Inc.announced today that it has achieved CE certification for the Corvia® Atrial Shunt System under the latest EU Medical Device Regulations (EU MDR 2017/745).

You may like
More>>

Desiccant use Japanese Paper

Desiccant use Japanese Paper
Desiccants use Japanese papaer

Desiccants use Japanese papaer
Stephania japonica extract Japanese Stephania Root extract Tabellae Cepharanthini extract

Stephania japonica extract Japanese Stephania Root extract Tabellae Cepharanthini extract
Ceremonial Green Japanese Face Instant Greentea Grade Halal Pure Oem Japan Organic Matcha Tea Powder

Ceremonial Green Japanese Face Instant Greentea Grade Halal Pure Oem Japan Organic Matcha Tea Powder
Japanese Pagodatree Flower-bud

Japanese Pagodatree Flower-bud
Stephania japonica extract Japanese Stephania Root extract Tabellae Cepharanthini extract Rotundine

Stephania japonica extract Japanese Stephania Root extract Tabellae Cepharanthini extract Rotundine
Organic Ceremonial Green Japanese Face Instant Greentea Grade Halal Pure Oem Japan Matcha Tea Powder

Organic Ceremonial Green Japanese Face Instant Greentea Grade Halal Pure Oem Japan Matcha Tea Powder
American standard Japanese standard German standard gate valve

American standard Japanese standard German standard gate valve
PHENOXYMETHYL PENICILLIN POTASSIUM

PHENOXYMETHYL PENICILLIN POTASSIUM
LINCOMYCIN HCL

LINCOMYCIN HCL

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service